What's new

Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 7, Status: Authorised

May 16, 2025 - 14:50
 0
Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 7, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Cerdelga, eliglustat, ...

Next Article

PV Price Watch: High inventory levels persist as Chinese polysilicon and wafer p...

Related Posts

EMA recommendation to update the antigenic composition ...

May 16, 2025  0

PSUSA/00010348/202409

PSUSA/00010348/202409

May 13, 2025  0

Human medicines European public assessment report (EPAR): Datroway, datopotamab deruxtecan, Date of authorisation: 04/04/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

May 13, 2025  0